Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

P2Y12 Receptor on the Verge of a Neuroinflammatory Breakdown.
[Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
Phenytoin in acute optic neuritis: neuroprotective or not?
[Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)].
The role of angiogenesis in the pathology of multiple sclerosis.
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
(18)F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
Systematic Review: The effectiveness of interventions to reduce falls and improve balance in adults with multiple sclerosis.
Opexa Therapeutics provides MS trial enrollment update; 70% of patients enrolled
Psychiatric disorders revealing multiple sclerosis after 20 years of evolvement.
Nitric oxide inhibits CXCL12 expression in neuroinflammation.
Chondroitin sulfate β-1,4-N-acetylgalactosaminyltransferase-1 (ChGN-1) polymorphism: Association with progression of multiple sclerosis.
Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis.
Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging.
Benchmarks of meaningful impairment on the MSFC and BICAMS.
The Incidence, Prevalence, Costs and Impact on Disability of Common Conditions Requiring Rehabilitation in the US: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain.
Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.
Development of the Cell Population in the Brain White Matter of Young Children.
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain.
Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial.
2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro.

Pages